Diana Reisinger

发表

Assessment of Treatment Response to Lenvatinib in Thyroid Cancer Monitored by F-18 FDG PET/CT Using PERCIST 1.0, Modified PERCIST and EORTC Criteria—Which One Is Most Suitable?

C. Pirich, W. Hitzl, H. Gallowitsch, 2022, Cancers.